Literature DB >> 22398465

Studies of isolated global brain ischaemia: I. Overview of irreversible brain injury and evolution of a new concept - redefining the time of brain death.

Bradley S Allen1, Gerald D Buckberg.   

Abstract

Despite advanced cardiac life support (ACLS), the mortality from sudden death after cardiac arrest is 85-95%, and becomes nearly 100% if ischaemia is prolonged, as occurs following unwitnessed arrest. Moreover, 33-50% of survivors following ACLS after witnessed arrest develop significant neurological dysfunction, and this rises to nearly 100% in the rare survivors of unwitnessed arrest. Although, whole body (cardiac) survival improves to 30% following recent use of emergency cardiopulmonary bypass, sustained neurological dysfunction remains a devastating and unresolved problem. Our studies suggest that both brain and whole body damage reflect an ischaemic/reperfusion injury that follows the present reperfusion methods that use normal blood, which we term 'uncontrolled reperfusion'. In contrast, we have previously introduced the term 'controlled reperfusion', which denotes controlling both the conditions (pressure, flow and temperature) as well as the composition (solution) of the reperfusate. Following prolonged ischaemia of the heart, lung and lower extremity, controlled reperfusion resulted in tissue recovery after ischaemic intervals previously thought to produce irreversible cellular injury. These observations underlie the current hypothesis that controlled reperfusion will become an effective treatment of the otherwise lethal injury of prolonged brain ischaemia, such as with unwitnessed arrest, and we tested this after 30 min of normothermic global brain ischaemia. This review, and the subsequent three studies will describe the evolution of the concept that controlled reperfusion will restore neurological function to the brain following prolonged (30 min) ischaemia. To provide a familiarity and rationale for these studies, this overview reviews the background and current treatment of sudden death, the concepts of controlled reperfusion, recent studies in the brain during whole body ischaemia, and then summarizes the three papers in this series on a new brain ischaemia model that endorses our hypothesis that controlled reperfusion allows complete neurological recovery following 30 min of normothermic global brain ischaemia. These findings may introduce innovative management approaches for sudden death, and perhaps stroke, because the brain is completely salvageable following ischaemic times thought previously to produce infarction.

Entities:  

Mesh:

Year:  2012        PMID: 22398465     DOI: 10.1093/ejcts/ezr315

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  13 in total

1.  Studies of isolated global brain ischaemia: III. Influence of pulsatile flow during cerebral perfusion and its link to consistent full neurological recovery with controlled reperfusion following 30 min of global brain ischaemia.

Authors:  Bradley S Allen; Yoshihiro Ko; Gerald D Buckberg; Zhong Tan
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-20       Impact factor: 4.191

2.  Studies of isolated global brain ischaemia: I. A new large animal model of global brain ischaemia and its baseline perfusion studies.

Authors:  Bradley S Allen; Yoshihiro Ko; Gerald D Buckberg; Sean Sakhai; Zhong Tan
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-20       Impact factor: 4.191

3.  Studies of isolated global brain ischaemia: II. Controlled reperfusion provides complete neurologic recovery following 30 min of warm ischaemia - the importance of perfusion pressure.

Authors:  Bradley S Allen; Yoshihiro Ko; Gerald D Buckberg; Zhong Tan
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-20       Impact factor: 4.191

4.  Adipose-derived mesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage.

Authors:  Tae Nyoung Chung; Jin Hee Kim; Bo Young Choi; Sung Phil Chung; Sung Won Kwon; Sang Won Suh
Journal:  Stem Cells Transl Med       Date:  2014-12-29       Impact factor: 6.940

5.  (+)-Naltrexone is neuroprotective and promotes alternative activation in the mouse hippocampus after cardiac arrest/cardiopulmonary resuscitation.

Authors:  Peter M Grace; Kaori Shimizu; Keith A Strand; Kenner C Rice; Guiying Deng; Linda R Watkins; Paco S Herson
Journal:  Brain Behav Immun       Date:  2015-03-13       Impact factor: 7.217

6.  Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice.

Authors:  S Nakayama; R Vest; R J Traystman; P S Herson
Journal:  J Mol Neurosci       Date:  2013-03-27       Impact factor: 3.444

7.  Examination of physiological function and biochemical disorders in a rat model of prolonged asphyxia-induced cardiac arrest followed by cardio pulmonary bypass resuscitation.

Authors:  Junhwan Kim; Tai Yin; Ming Yin; Wei Zhang; Koichiro Shinozaki; Mary A Selak; Kirk L Pappan; Joshua W Lampe; Lance B Becker
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

8.  Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage.

Authors:  A Hadanny; H Golan; G Fishlev; Y Bechor; O Volkov; G Suzin; E Ben-Jacob; S Efrati
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

9.  DHA-supplemented diet increases the survival of rats following asphyxia-induced cardiac arrest and cardiopulmonary bypass resuscitation.

Authors:  Junhwan Kim; Tai Yin; Koichiro Shinozaki; Joshua W Lampe; Lance B Becker
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

10.  Potential targets for protecting against hippocampal cell apoptosis after transient cerebral ischemia-reperfusion injury in aged rats.

Authors:  Xiangyu Ji; Li'na Zhang; Ran Liu; Yingzhi Liu; Jianfang Song; He Dong; Yanfang Jia; Zangong Zhou
Journal:  Neural Regen Res       Date:  2014-06-01       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.